About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Multiple Sclerosis Clinical Trials in Houston | 108 Studies

Clinical Trials Multiple SclerosisHouston

Multiple Sclerosis Clinical Trials in Houston

Find 108 clinical trials for multiple sclerosis near Houston, Texas. Connect with research centers in your area.

All Multiple Sclerosis trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 1-20 of 108 trials

CompletedA Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple SclerosisThis randomized, double-blind, double-dummy, parallel-group study will evaluate the efficacy and safety of ocrelizumab in comparison with interferon beta-1a (Rebif) in…NCT01412333·Phoenix, Arizona and 164 others

Multiple Sclerosis Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedJC Virus Antibody Study of Participants With Relapsing Forms of MS Receiving Treatment With NatalizumabThe primary objective of this study is to demonstrate that the incidence of progressive multifocal Leukoencephalopathy (PML) in natalizumab-treated participants who do not have…NCT01070836·Birmingham, Alabama and 477 others

CompletedEfficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis With Optional Extension PhaseThis study assessed the safety, tolerability, and efficacy of 2 doses of oral fingolimod versus interferon β-1a to reduce the frequency of relapses in patients with…NCT00340834·Cullman, Alabama and 169 others

CompletedAssessment of ANK-700 in Patients With Relapsing Remitting Multiple SclerosisA safety study of ANK-700 in patients with relapsing remitting multiple sclerosis.NCT04602390·Cullman, Alabama and 14 others

CompletedA Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple SclerosisThis study seeks to evaluate the safety, tolerability, pharmacokinetics (PK) and immunogenicity of ABT-555 in participants with relapsing forms of multiple sclerosis (RFMS).NCT02601885·Orlando, Florida and 7 others

RecruitingThe SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot StudyThe MS pilot study will assess the safety and investigate the remyelinating effects of the SetPoint System (study device) in adult patients diagnosed with relapsing-remitting…NCT06796504·Irvine, California and 8 others

WithdrawnA Study of Pirtobrutinib (LY3527727 [LOXO-305]) Versus Placebo in Participants With Relapsing Multiple SclerosisThe main purpose of this study is to assess efficacy and safety of pirtobrutinib in participants with relapsing multiple sclerosis.NCT06104683·Tampa, Florida and 3 others

CompletedEnvironmental and Genetic Risk Factors for Pediatric Multiple SclerosisThe purpose of this study is to better understand multiple sclerosis (MS) in children and adolescents, to learn if it differs from adult MS and to investigate if genes or…NCT01396343·Birmingham, Alabama and 16 others

CompletedAT RISK FOR MS - Clinical Conversion of Female Monozygotic Twins Discordant for CIS/MSThe definition of the most 'at-risk' population within highly susceptible groups would provide an opportunity for preemptive therapeutics.NCT00617383·Houston, Texas

RecruitingNeuromodulating Cortical Regions Involved in Neurogenic Bladder in MSNeurogenic overactive bladder (NOAB), characterized by urinary frequency, urgency or urgency incontinence symptoms occurring during the storage phase of the bladder, is the most…NCT06072703·Houston, Texas

CompletedAn Open-label Study Evaluating Ofatumumab Treatment Effectiveness and PROs in Subjects With RMS Transitioning From Fumarate-based RMS Approved Therapies or Fingolimod to OfatumumabOpen-label study to evaluate the effectiveness of treatment with ofatumumab in subjects transitioning from any fumarate-based RMS approved therapy or fingolimod due to…NCT04353492·Fullerton, California and 122 others

CompletedAdherence in Pediatric Multiple SclerosisDisease modifying therapies (DMT) are widely used for children and adolescents with MS. Nonetheless, many pediatric patients continue to relapse and therefore require changes in…NCT02234713·Birmingham, Alabama and 12 others

RecruitingMultiple Sclerosis Implementation Network (Registry)The Multiple Sclerosis Implementation Network (MSIN) is a collaboration between the Multiple Sclerosis Association of America (MSAA), The University of Texas Health Science Center…NCT07415824·Cherry Hill, New Jersey and 2 others

TerminatedStudy of Evobrutinib in Participants With RMS (evolutionRMS 1)The study is to evaluate the efficacy and safety of evobrutinib administered orally twice daily versus Teriflunomide (Aubagio®), administered orally once daily in participants…NCT04338022·Mobile, Alabama and 278 others

CompletedNonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (HERCULES)Primary Objective: To determine the efficacy of SAR442168 compared to placebo in delaying disability progression in NRSPMS Secondary Objective: To evaluate efficacy of…NCT04411641·Birmingham, Alabama and 305 others

CompletedWearable Lower Extremity Exoskeleton to Promote Walking in Persons With Multiple SclerosisThe purpose of this study is to investigate whether a wearable robotic exoskeleton can help people with multiple sclerosis (MS) to walk again.NCT02519244·Houston, Texas

CompletedCombination Therapy in Patients With Relapsing-Remitting Multiple Sclerosis (MS)CombiRxThis is for a randomized clinical trial (RCT) to determine if the combined use of interferon beta-1a (IFN) and glatiramer acetate (GA) is a measurably better therapy than either…NCT00211887·Birmingham, Alabama and 70 others

CompletedStudy of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple SclerosisThe purpose of this study is to determine whether Tcelna (imilecleucel-T, autologous T-Cell Immunotherapy) is effective in the treatment of secondary progressive multiple…NCT01684761·Phoenix, Arizona and 35 others

CompletedOpen-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR Tablets in Multiple Sclerosis Patients Who Participated in the MS-F203 TrialThe purpose of this study is to evaluate the safety, tolerability and activity of Fampridine-SR when administered for up to 36 additional months, or until it becomes commercially…NCT00648908·Phoenix, Arizona and 31 others

CompletedEfficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple SclerosisThis study assessed the safety, tolerability and efficacy of two doses of oral fingolimod compared to placebo on efficacy parameters in patients with relapsing-remitting multiple…NCT00355134·Birmingham, Alabama and 111 others

Page 1 of 6Next

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia